The company has received final approval from the US Food and Drug Administration (US FDA) to market metronidazole tablets in strengths of 2...

The Mumbai-based company's product is the generic equivalent of Daiichi Sankyo Inc's Benicar tablets which is indicated for the treatment o...

Fluocinonide topical solution USP, 0.05% clocked sales of $32.4 million in the US, Lupin said in a release citing IMS MAT March 2017 data.

As per IMS MAT December 2016 data "Temovate clobetasol propionate scalp application had US sales of $64.1 million", Lupin said.

The approval is for multiple strengths of 0.025 per cent, 0.1 per cent and 0.5 per cent triamcinolone acetonide cream, said the company.

The company's product is a generic version of Daiichi Sankyo Inc's Evoxac capsules, it added.

The firm has received tentative approval from United States Food and Drug Administration to market its Pitavastatin tablets in the strength...

As per IMS MAT sales data, Hydrocodone Bitartrate and Acetaminophen tablets had sales of USD 89.6 million in the US market.

The company's product is indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and pre...

Gavis has received tentative approval for its Azithromycin for oral suspension USP from the USFDA, Lupin said in a BSE filing.

Shalu Munka has a bachelor’s degree in business administration and managed a perfect score in the management aptitude test.

Lupin said it has received final approval from the US drug regulator to market generic Aricept tablets used for treatment of dementia.

The company's US subsidiary, Lupin Pharmaceuticals Inc has launched the generic Niaspan tablets in multiple strengths of 500mg, 750 mg & 10...

Lupin said its US arm has launched generic Fenofibric Acid capsules used for reducing cholesterol and fatty acids in the blood in the Ameri...

With the US GDP forecast to grow at 2.5-3%, companies are seeing strong demand and high visibility on order inflows.

Indian pharmaceutical market, which has registered robust growth in last few years, was valued at over Rs 55,000 crore in the last fiscal, ...

Ranbaxy Laboratories has got approval from Health Canada, Therapeutic Products Directorate to manufacture and market Lisinopril 5, 10 and 2...